| Date | Valeur | Objet de la publication | Opinion | Cours | Objectif de cours |
|---|---|---|---|---|---|
| 15/12/2022 | Capelli | RN S1 2022/23 | Achat | 13,05€ | 17,9€ (vs 29€) |
| 02/12/2022 | Miliboo | CA S1 2022/23 | Achat | 2,30€ | 4,76€ (5,15€) |
| 25/11/2022 | Adux | CA + EBITDA T3 | Achat | 1,53€ | 2,71€ |
| 10/11/2022 | Uniti | RN S1 | Achat | 2,04 € | 2,87€ (vs 3€) |
| 10/11/2022 | Equasens | CA T3 | Achat | 70,9 € | 87,3€ |
| 09/11/2022 | Airwell | CA T3 | Achat | 3,3€ | 4,26€ (vs 4,15€) |
| 09/11/2022 | M2i | CA T3 | Achat | 3,5€ | 6,31€ |
| 09/11/2022 | Prologue | CA T3 | Achat | 0,266€ | 0,36€ (vs 0,38€) |
| 08/11/2022 | Delta Plus | CA T3 | Achat | 63,2€ | 103,6€ |
| 03/11/2022 | Adomos | CA+RN S1 | Sous Revue | 0,0075€ | Sous Revue |
| 03/11/2022 | Sogeclair | CA T3 | Achat | 17,2€ | 26,6€ |
| 01/11/2022 | Blockchain Group | RN S1 | Achat | 0,452€ | 0,85€ (vs 1,48€) |
| 28/10/2022 | Paulic Meunerie | RN S1 | Achat | 2,385€ | 3,83€ (vs 4,53€) |
| 25/10/2022 | Egide | RN S1 | Neutre | 0,717€ | 0,78€ (vs 1,13 €) |
| 21/10/2022 | Reworld Media | CP | Achat | 5,50€ | 11,21€ |
| 21/10/2022 | Showroomprivé | CA T3 | Achat | 1,55€ | 2,12€ (vs 2,20€) |
| 20/10/2022 | Invibes | CA T3 | Achat | 10,35€ | 18,70€ (vs 25,96€) |
| 19/10/2022 | Mint | RN S1 | Achat | 1,956€ | 4,01€ (vs 6,04€) |
| 07/10/2022 | Safe Orthopaedics | RN S1 + CA T3 | Neutre | 0,0061€ | Sous Revue |
| 03/10/2022 | M2i | RN S1 | Achat | 3,42€ | 6,31€ (vs 7,05€) |
| 03/10/2022 | Prologue | RN S1 | Achat | 0,274€ | 0,38€ (vs 0,50€) |
| 28/09/2022 | Egide | CP | Achat Spec. (vs Achat) | 0,63€ | 1,13€ (vs 1,45€) |
| 26/09/2022 | Showroomprivé.com | Initiation | Achat | 1,173€ | 2,20€ |
| 23/09/2022 | Equasens | RN S1 | Achat | 70,2€ | 87,3€ (vs 103,1€) |
| 22/09/2022 | Nextedia | RN S1 | Achat | 0,867€ | 1,34€ (vs 1,50€) |
| 22/09/2022 | Reworld Media | CA+RN S1 | Achat | 6,63€ | 11,21€ (vs 11,35€) |
| 21/09/2022 | Airwell | RN S1 | Achat | 3,52€ | 4,15 € (vs 5,25€) |
| 20/09/2022 | Blockchain Group | CP | Achat | 0,66€ | 1,48€ (vs 1,70€) |
| 09/09/2022 | Delta Plus | CP | Achat | 65€ | 103,6€ (vs 101€) |
| 09/09/2022 | Miliboo | CA T1 2022/23 | Achat | 3,03€ | 5,15€ (vs 5,19€) |
| 08/09/2022 | Invibes | RN S1 | Achat | 13,40€ | 25,96€ (vs 27,77€) |
| 08/09/2022 | Sogeclair | RN S1 | Achat | 21,9€ | 26,6€ (vs 28,5€) |
| 06/09/2022 | Delta PLus | RN S1 | Achat | 67,6€ | 101€ (vs 106,6 €) |
| 04/08/2022 | Equasens (ex Pharmagest) | CA S1 | Achat | 84,2€ | 103,1€ (vs 112,7€) |
| 29/07/2022 | Adux | CA S1 | Achat | 1,75€ | 3,22€ (vs 3,51€) |
| 28/07/2022 | Capelli | CA S1 | Achat | 14,75€ | 29€ |
| 28/07/2022 | Delta Plus | CA S1 | Achat | 70€ | 106,6€ |
| 28/07/2022 | Mint | CA S1 | Achat | 2,96€ | 6,04€ (vs 10,71€) |
| 26/07/2022 | M2I | CA S1 | Achat | 4,08€ | 7,05€ (vs 6,92€) |
| 26/07/2022 | Prologue | CA S1 | Achat | 0,232€ | 0,50€ (vs 0,60€) |
| 22/07/2022 | Egide | CA S1 | Achat | 0,863€ | 1,45€ (vs 1,78€) |
| 21/07/2022 | Blockchain Group | CA S1 | Achat | 0,8955€ | 1,70€ (vs 1,85€) |
| 21/07/2022 | Invibes | CA S1 | Achat | 17,5€ | 27,77€ (vs 30,1€) |
| 21/07/2022 | Nextedia | CA S1 | Achat | 0,966€ | 1,5€ (vs 1,66€) |
| 21/07/2022 | Sogeclair | CA S1 | Achat | 21,5€ | 28,5€ |
| 20/07/2022 | Airwell | CA S1 | Achat | 3,54€ | 5,25€ (vs 5,10€) |
| 15/07/2022 | Miliboo | RN 2021/22 | Achat | 3,18€ | 5,19€ |
| 12/07/2022 | Paulic | CA S1 | Achat | 2,83€ | 4,53€ (vs 5,31€) |
| 11/07/2022 | Safe Orthopaedics | CA S1 | Neutre (vs Achat Spec) | 0,0327€ | Sous Revue (vs 0,25€) |
| 04/07/2022 | Miliboo | CP | Achat | 2,95 € | 5,19€ |
| 01/07/2022 | Nextedia | CP | Achat | 0,92€ | 1,66€ |
| 29/06/2022 | Reworld Media | CP | Achat | 6,82€ | 11,35€ |
| 29/06/2022 | Capelli | RN 2021/22 | Achat | 16,05€ | 29€ |
| 29/06/2022 | Egide | CP | Achat | 0,94€ | 1,78€ |
| 20/06/2022 | Egide | CP | Achat | 0,87€ | 1,78€ |
| 02/06/2022 | Uniti | RN 2021 | Achat | 2,54€ | 3€ (vs 3,46€) |
| 01/06/2022 | Miliboo | CA 2021/22 | Achat | 3,315€ | 5,19€ (vs 7,79€) |
| 25/05/2022 | Capelli | CA 2021/22 | Achat | 19,75€ | 29€ (vs 32,4€) |
| 20/05/2022 | Adux | CA T1 | Achat | 1,90€ | 3,61€ (vs 3,27€) |
| 13/05/2022 | Equasens (ex. Pharmagest) | CA T1 | Achat | 75,2€ | 112,7€ |
| 13/05/2022 | M2i | CA T1 | Achat | 4,08€ | 6,92€ |
| 13/05/2022 | Prologue | CA T1 | Achat | 0,274€ | 0,60€ |
| 11/05/2022 | Airwell | CA T1 | Achat | 3,7€ | 5,1€ |
| 10/05/2022 | Adomos | CP | Sous Revue | 0,0328€ | Sous Revue |
| 06/05/2022 | Delta Plus | CA T1 | Achat | 88,8€ | 109,6€ |
| 05/05/2022 | Sogeclair | CA T1 | Achat | 22,5€ | 28,5€ |
| 02/05/2022 | Blockchain Group | CA+RN 2021 | Achat | 1,268€ | 1,85€ (vs 2,05€) |
| 02/05/2022 | Mint | RN 2021 | Achat | 3,70€ | 10,71€ (vs 8,49€) |
| 02/05/2022 | Prologue | RN 2021 | Achat | 0,273€ | 0,60€ |
| 02/05/2022 | M2i | RN 2021 | Achat | 4,52€ | 6,92€ |
| 02/05/2022 | Safe Orthopaedics | RN 2021 | Achat Spec. | 0,109€ | 0,25€ |
| 28/04/2022 | Airwell | RN 2021 | Achat | 3,7€ | 5,1€ |
| 25/04/2022 | Reworld Media | CP | Achat | 6,85€ | 11,35€ |
| 22/04/2022 | Paulic | RN 2021 | Achat | 3,50€ | 5,31€ (vs 7,90€) |
| 21/04/2022 | Invibes | CA T1 | Achat | 17,60€ | 30,10€ |
| 15/04/2022 | Safe | CA T1 + Visite de site | Achat Spec. | 0,1232€ | 0,45€ |
| 08/04/2022 | Adux | RN 2021 | Achat | 2,41€ | 3,27€ |
| 05/04/2022 | Delta Plus | RN 2021 | Achat | 89,6€ | 109,6€ |
| 04/04/2022 | Adomos | RN 2021 | Sous Revue | 0,0325€ | Sous Revue |
| 31/03/2022 | Egide | RN 2021 | Achat | 1,44€ | 1,78€ |
| 31/03/2022 | Nextedia | RN 2021 | Achat | 1,024€ | 1,66€ (vs 1,75€) |
| 28/03/2022 | Pharmagest | RN 2021 | Achat | 82,9€ | 112,7€ (vs 124,8€) |
| 24/03/2022 | Reworld Media | CA+RN 2021 | Achat | 6,25€ | 11,35€ (vs 10,12€) |
| 23/03/2022 | Invibes | RN 2021 | Achat | 17,8€ | 30,1€ (vs 31,77€) |
| 21/03/2022 | Safe | CP | Achat Spec. | 0,1314€ | 0,45€ (vs 0,59€) |
| 17/03/2022 | Sogeclair | RN 2021 | Achat | 21,9€ | 28,5€ (vs 29,8€) |
| 02/03/2022 | Delta Plus | CP | Achat | 80,2€ | 109,6€ |
| 25/02/2022 | Adux | CA+EBITDA 2021 | Achat | 2,08€ | 3,27€ (vs 3,46€) |
| 25/02/2022 | Miliboo | CA T3 2021/22 | Achat | 4,09€ | 7,79€ (vs 8,01€) |
| 25/02/2022 | Mint | CP | Achat | 3,40€ | 8,49€ |
| 17/02/2022 | Nextedia | CA 2021 | Achat | 1,078€ | 1,75€ (vs 1,65€) |
| 15/02/2022 | M2i | CA 2021 | Achat | 5,15€ | 6,92€ (vs 8,78€) |
| 15/02/2022 | Prologue | CA 2021 | Achat | 0,344€ | 0,60€ (vs 0,74€) |
| 15/02/2022 | Mint | CA 2021 | Achat | 4,68€ | 8,49€ (vs 9,28€) |
| 11/02/2022 | Delta Plus | CA 2021 | Achat | 90,30€ | 109,6€ (vs 116,7€) |
| 08/02/2022 | Adomos | CA 2021 | Sous Revue (vs Achat) | 0,0674€ | Sous Revue (vs 0,52€) |
| 07/02/2022 | Pharmagest | CA 2021 | Achat | 77,1€ | 124,8€ (vs 143,2€) |
| 03/02/2022 | Capelli | CA T3 | Achat | 26,4€ | 32,4€ (vs 37,1€) |
| 03/02/2022 | Reworld | CP | Achat | 6,50€ | 10,12€ |
| 03/02/2022 | Sogeclair | CA 2021 | Achat | 25,1€ | 29,8€ (vs 27€) |
| 27/01/2022 | Invibes | CP | Achat | 20,4€ | 31,77€ (vs 32,27€) |
| 26/01/2022 | Egide | CA 2021 | Achat | 1,595€ | 1,78€ (vs 1,85€) |
| 25/01/2022 | Airwell | CA 2021 | Achat | 3,55€ | 5,1€ |
| 19/01/2022 | Delta Plus | Acquisition | Achat (vs Neutre) | 87,3€ | 116,7€ (vs 100,4€) |
| 18/01/2022 | Invibes | CA 2021 | Achat | 21,4€ | 32,27€ (30,29€) |
| 18/01/2022 | Paulic | CA 2021 | Achat | 4,14€ | 7,90€ |
| 14/01/2022 | Safe | CA 2021 | Achat Spec. | 0,2775€ | 0,59€ (vs 0,65€) |
| 12/01/2022 | Miliboo | RN S1 2021/22 | Achat | 5,14€ | 8,01€ (vs 8,11€) |
